Immutep to Present at Investor Conferences

2022-05-20T12:00:00Z

SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announces Immutep has been invited to present at investor conferences, as outlined below.

Wilsons Rapid Insights 26 May 2022
Presenter: Marc Voigt, CEO and Deanne Miller, COO of Immutep
Presentation time & date: All day on 26 May
Format: In-person conference, 45-minute small group briefings with Q&A
Venue: Four Seasons Hotel Sydney, 199 George St, The Rocks, Sydney NSW 2000 Australia
InformationInstitutional investors should contact Wilsons Corporate Access: Jeanne.Truijens@wilsonsadvisory.com.au or visit: www.wilsonsrapidinsights.com.au

Jefferies Australia MedTech/Biotech Summit 26 & 27 May 2022
Presenter: Marc Voigt, CEO of Immutep
Presentation time & date: 9.00am AEST on Friday 27 May
Format: This conference will be a virtual format
Information: Please contact your Jefferies representative to register. For questions, please email healthcareconference@jefferies.com

Jefferies Global Healthcare Conference – 8 to 10 June 2022
Presenter: Marc Voigt, CEO of Immutep
Presentation time & date: 8:30 AM ET on 10 June
Format: In-person conference, with one to one investor meetings available
Venue: in New York City on June 8-10, 2022
Information: For questions, please email healthcareconference@jefferies.com
                     A live webcast and replay of the presentation will be made available at
                     https://wsw.com/webcast/jeff240/immp/1851075
                     and on the Company’s website following the event.

About Immutep
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease. Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders. Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States.

Immutep’s current lead product candidate is eftilagimod alpha (“efti” or “IMP321”), a soluble LAG-3 fusion protein (LAG-3Ig), which is a first-in-class antigen presenting cell (APC) activator being explored in cancer and infectious disease. Immutep is also developing an agonist of LAG-3 (IMP761) for autoimmune disease. Additional LAG-3 products, including antibodies for immune response modulation, are being developed by Immutep’s large pharmaceutical partners.

Further information can be found on the Company’s website www.immutep.com or by contacting:

Australian Investors/Media:
Catherine Strong, Citadel-MAGNUS
+61 (0)406 759 268; cstrong@citadelmagnus.com

U.S. Media:
Tim McCarthy, LifeSci Advisors
+1 (212) 915.2564; tim@lifesciadvisors.com

 


Globe Newswire News

RSS Australian Mining Releases

  • Xanadu Mines Date of 2024 Annual General Meeting
    TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (“Xanadu” or “the Company”) is pleased to advise that in accordance with ASX Listing Rule 3.13.1, Xanadu will hold its 2024 Annual General Meeting on: Date: Thursday, 23 May 2024Time: 11:00am AESTLocation: Victoria Hotel  215 Little Collins Street  Melbourne Victoria 3000  Australia    The closing date for the […]
  • Drilling Underway at Red Mountain Project
    Figure 1 Map of Mongolia, showing location of the Red Mountain Mining Lease. Figure 2 The Red Mountain Mining Lease with designed drill holes and target locations. Figure 3 Exploration drilling has commenced at Red Mountain. Figure 4 Target 33 showing previous drilling and trenching(2) and planned drilling 2024. Figure 5 Target 10 showing previous […]
  • Kharmagtai Water Supply Drilling Program Recommences
    Figure 1 PFS Water Drilling in ZUK Basin Figure 2 Drilling Water Monitoring Hole at ZUK Basin TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to announce that the hydrological drilling program has re-commenced for the Kharmagtai Pre-Feasibility Study (PFS), which is […]
  • MCB Project Mining Permit granted by Philippine Government
    HIGHLIGHTS The Philippine Department of Environment and Natural Resources has approved MCB’s mining permit on 15 March 2024, valid for 25 years and renewable for another 25 years. The permit grants the Company exclusive rights to undertake rational exploration, development, and commercial production of copper and associated minerals.The issuance of the mining permit will enable […]
  • Xanadu Mines Ltd (ASX Code: XAM) Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
    TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- This notice is given by Xanadu Mines Ltd (ACN 1144 249 026) (Xanadu Mines or the Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act). Xanadu Mines advises that on 4 March 2024, it issued 15,185,328 fully paid ordinary shares at a price of $0.055 per […]
  • Encouraging oxide leach recovery for copper & gold at Kharmagtai
    Figure 1 Oxide Column Leach at DMPS Labs Figure 2 Oxide Layer Over White Hill & Stockwork Hill – Cross Section Looking West Figure 3 Collar locations for drill holes sampled in metallurgical testwork TORONTO, March 06, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased […]
  • Completion of Placement to Zijin Mining
    TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce that the placement of 15,185,328 fully paid ordinary shares to Jinping (Singapore) Mining Pte Ltd, a wholly owned indirect subsidiary of Zijin Mining Group Co. Ltd (Zijin), at an issue price of A$0.055 per share, […]
  • Completion of Placement to Zijin Mining
    TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce that the placement of 15,185,328 fully paid ordinary shares to Jinping (Singapore) Mining Pte Ltd, a wholly owned indirect subsidiary of Zijin Mining Group Co. Ltd (Zijin), at an issue price of A$0.055 per share, […]
  • Metallurgical Tests at Kharmagtai Show Strong Sulphide Rougher Flotation Recovery
    Figure 1 Copper Grade vs Rougher Recovery Figure 2 Conventional flowsheet (simplified) Figure 3 Copper Rougher Recovery versus Grind Size Figure 3 Collar locations for drill holes sampled in metallurgical test work TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to provide […]
  • Perseus Mining Half Year Results
    perth, Feb. 23, 2024 (GLOBE NEWSWIRE) -- PERSEUS MINING BOOSTS AFTER TAX HY PROFIT BY 21% TO US$165M & INCREASES NET CASH & BULLION TO US$642M Perth, Western Australia/February 23, 2024/Mid-tier, African focused gold producer, developer and explorer, Perseus Mining Limited (ASX/TSX:PRU) has reported material improvements across all key financial metrics including revenue, EBITDA, profit […]

Stay up to date

Get notified about the latest gold mining news as soon as it happens or choose daily or weekly deliveries.
GET Newsletters
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram